Science Explorer Back to mapMap
Discussion
Company · Madison · United States

Leo Pharma (United States)

leo-pharma.usROR OpenAlex
Research works
18
▲ 254% vs 2018-21
Citations
51
2.8 per fractional work
Top-10% rate
10.0%
all institutions 10.0%
Open access
74%
world 40%
International
60%
world 18%
Leo Pharma (United States)

Not ranked overall: Leo Pharma (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Leo Pharma (United States) work in?

In all years, 80% of research at Leo Pharma (United States) is in Health Sciences, 15% in Life Sciences. Its largest fields are Medicine (77%), Immunology and Microbiology (13%), Health Professions (3%). It does 2.4× the world's share of Health Sciences.

Health Sciences: 14 fractional works · 80.2% of its workMedicine: 14 fractional works · 77.2% of its workDermatology: 7 fractional works · 37.2% of its workRheumatology: 2 fractional works · 9.9% of its workPhysiology: 1 fractional works · 7.9% of its workImmunology and Allergy: 1 fractional works · 6.1% of its workEpidemiology: 1 fractional works · 5.8% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 2.7% of its workPsychiatry and Mental health: 0 fractional works · 1.6% of its workPathology and Forensic Medicine: 0 fractional works · 1.3% of its workOncology: 0 fractional works · 0.9% of its workPharmacology: 0 fractional works · 0.9% of its workEmergency Medicine: 0 fractional works · 0.6% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.6% of its workComplementary and alternative medicine: 0 fractional works · 0.4% of its workInfectious Diseases: 0 fractional works · 0.4% of its workSurgery: 0 fractional works · 0.4% of its workGastroenterology: 0 fractional works · 0.3% of its workHealth Professions: 1 fractional works · 2.9% of its workGeneral Health Professions: 0 fractional works · 1.8% of its workEmergency Medical Services: 0 fractional works · 0.6% of its workSpeech and Hearing: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workLife Sciences: 3 fractional works · 15.0% of its workImmunology and Microbiology: 2 fractional works · 12.6% of its workImmunology: 2 fractional works · 12.6% of its workBiochemistry, Genetics and Molecular Biology: 0 fractional works · 1.6% of its workBiotechnology: 0 fractional works · 1.2% of its workCell Biology: 0 fractional works · 0.2% of its workGenetics: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.6% of its workPharmaceutical Science: 0 fractional works · 0.4% of its workPharmacology: 0 fractional works · 0.2% of its workNeuroscience: 0 fractional works · 0.2% of its workBehavioral Neuroscience: 0 fractional works · 0.2% of its workSocial Sciences: 1 fractional works · 3.0% of its workEconomics, Econometrics and Finance: 0 fractional works · 2.6% of its workEconomics and Econometrics: 0 fractional works · 2.6% of its workPsychology: 0 fractional works · 0.4% of its workClinical Psychology: 0 fractional works · 0.4% of its workPhysical Sciences: 0 fractional works · 1.8% of its workEnvironmental Science: 0 fractional works · 1.8% of its workGlobal and Planetary Change: 0 fractional works · 0.9% of its workPollution: 0 fractional works · 0.9% of its workALL ITS WORKLeo Pharma(United States)18fractional works, all years
Life Sciences15%Physical Sciences2%Health Sciences80%Social Sciences3%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 9 fields, with their numbers
    1. Medicine1477.2%
    2. Health Professions12.9%
    1. Immunology and Microbiology212.6%
    2. Biochemistry, Genetics and Molecular Biology01.6%
    3. Pharmacology, Toxicology and Pharmaceutics00.6%
    4. Neuroscience00.2%
    1. Economics, Econometrics and Finance02.6%
    2. Psychology00.4%
    1. Environmental Science01.8%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 0.39× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 10.57× its world share, 2 worksImmunology and Micro…Neuroscience: 0.18× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.84× its world share, 0 worksPharmacology, Toxico…Environmental Science: 0.48× its world share, 0 worksEnvironmental ScienceHealth Professions: 1.13× its world share, 0 worksHealth ProfessionsMedicine: 4.12× its world share, 11 worksMedicineEconomics, Econometrics and Finance: 0.78× its world share, 0 worksEconomics, Econometr…Psychology: 0.16× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 10.6×. Every wedge is a field page.

All 9 fields, with their numbers
  1. Immunology and Microbiology10.57×2 works
  2. Medicine4.12×11 works
  3. Health Professions1.13×0 works
  4. Pharmacology, Toxicology and Pharmaceutics0.84×0 works
  5. Economics, Econometrics and Finance0.78×0 works
  6. Environmental Science0.48×0 works
  7. Biochemistry, Genetics and Molecular Biology0.39×0 works
  8. Neuroscience0.18×0 works
  9. Psychology0.16×0 works

Who are the top researchers at Leo Pharma (United States)?

Ranked on the quality score, Sanjeev Balu, Karen A. Veverka and Shannon K. R. Schneider lead among researchers whose main affiliation is Leo Pharma (United States).

  1. 1 Sanjeev Balu United States · #2,965,154 worldwide 1.3k citations · 107 works
  2. 2 Karen A. Veverka United States · #3,243,674 worldwide 726 citations · 39 works
  3. 3 Shannon K. R. Schneider United States · #4,367,967 worldwide 59 citations · 31 works
All ranked researchers at Leo Pharma (United States)

What are the most cited papers from Leo Pharma (United States)?

The most cited paper from Leo Pharma (United States) is "Long-term 2-year safety and efficacy of tralokinumab in adults with moderate-to-severe atopic dermatitis: Interim analysis of the ECZTEND open-label extension trial" (Andrew Blauvelt, Richard G B Langley, J.‐P. Lacour et al., 2022), with 79 citations. Next come "Tralokinumab therapy for moderate‐to‐severe atopic dermatitis: Clinical outcomes with targeted IL ‐13 inhibition" (41) and "Safety and Efficacy of Tralokinumab in Older Adults With Moderate-to-Severe Atopic Dermatitis" (23).

Most cited papers
#PaperReleasedCitations
1 Long-term 2-year safety and efficacy of tralokinumab in adults with moderate-to-severe atopic dermatitis: Interim analysis of the ECZTEND open-label extension trial Andrew Blauvelt, Richard G B Langley, J.‐P. Lacour et al. · Journal of the American Academy of Dermatology Open access 18 Jul 2022 79
2 Tralokinumab therapy for moderate‐to‐severe atopic dermatitis: Clinical outcomes with targeted IL ‐13 inhibition Eric Lawrence Simpson, Emma Guttman‐Yassky, Lawrence F. Eichenfield et al. · Allergy Open access 16 Jul 2023 41
3 Safety and Efficacy of Tralokinumab in Older Adults With Moderate-to-Severe Atopic Dermatitis Joseph Frank Merola, Daniel C. Butler, Thomas Mark et al. · JAMA Dermatology Open access 23 Aug 2023 23
4 Patient-oriented measures for phase 3 studies of tralokinumab for the treatment of atopic dermatitis (ECZTRA 1, 2, and 3) Eric Lawrence Simpson, Andreas Wollenberg, Weily Soong et al. · Annals of Allergy Asthma & Immunology Open access 14 Jul 2022 18
5 Real-world experience of calcipotriene and betamethasone dipropionate foam 0.005%/0.064% in the treatment of adults with psoriasis in the United States Jashin J. Wu, Karen A. Veverka, Minyi Lu et al. · Journal of Dermatological Treatment 11 Oct 2018 18
All 74 most cited papers, with filters and sorting

Which research topics does Leo Pharma (United States) publish most on?

By volume in 2022-now: Dermatology and Skin Diseases, Contact Dermatitis and Allergies, Asthma and respiratory diseases and Urticaria and Related Conditions.

Dermatology and Skin Dis…4Dermatology and Skin Diseases: 4 fractional worksContact Dermatitis and A…1Contact Dermatitis and Allergies: 1 fractional worksAsthma and respiratory d…1Asthma and respiratory diseases: 1 fractional worksUrticaria and Related Conditions: 1 fractional worksPsoriasis: Treatment and Pathogenesis: 1 fractional worksFood Allergy and Anaphyl…1Food Allergy and Anaphylaxis Research: 1 fractional worksAllergic Rhinitis and Sensitization: 0 fractional worksSkin Diseases and Diabetes: 0 fractional worksNail Diseases and Treatments: 0 fractional worksBiosimilars and Bioanalytical Methods: 0 fractional works
DermatologyPhysiologyRheumatologyImmunology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Dermatology and Skin Diseases Dermatology 4 works
  2. 2 Contact Dermatitis and Allergies Dermatology 1 works
  3. 3 Asthma and respiratory diseases Physiology 1 works
  4. 4 Urticaria and Related Conditions Rheumatology 1 works
  5. 5 Psoriasis: Treatment and Pathogenesis Immunology 1 works
  6. 6 Food Allergy and Anaphylaxis Research Immunology and Allergy 1 works
  7. 7 Allergic Rhinitis and Sensitization Immunology and Allergy 0 works
  8. 8 Skin Diseases and Diabetes Dermatology 0 works
  9. 9 Nail Diseases and Treatments Epidemiology 0 works
  10. 10 Biosimilars and Bioanalytical Methods Immunology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available74.0%not open26.0%

World: 40% of research is openly available.

with international co-authors60.3%domestic only39.7%

World: 18% is written across borders.

How has Leo Pharma (United States)'s research output changed?

Output in 2022-2025 was 254% higher than in 2018-2021.

still counting201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Madison

All research institutions in Madison

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Leo Pharma (United States). Posts are plain text and can be reported.